Cardiac dysfunction after cancer treatment. - Wikidata - thesis-toulmin - TriplyDB

Cardiac dysfunction after cancer treatment.

Cardiac dysfunction after cancer treatment.

http://www.wikidata.org/entity/Q35039549

about

Radiotherapy and anthracyclines - cardiovascular toxicity Cardiorespiratory fitness in breast cancer survivors Oxytocin and cancer: An emerging link

P2860

Q35648956-EFC6B006-1BFC-46D9-817F-3EE1E1E2667B Q36710842-F303F69A-3A66-4950-B708-B4407AD55417 Q57157454-37729F32-D8BB-45EE-B1C4-A942E3ACA95A

P2860

Cardiac dysfunction after cancer treatment.

http://www.wikidata.org/entity/Q35039549

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Cardiac dysfunction after cancer treatment.

@ast

Cardiac dysfunction after cancer treatment.

@en

type

label

Cardiac dysfunction after cancer treatment.

@ast

Cardiac dysfunction after cancer treatment.

@en

prefLabel

Cardiac dysfunction after cancer treatment.

@ast

Cardiac dysfunction after cancer treatment.

@en

P1433

Q35039549-7560D983-A6D4-499E-B962-71879122C733

P1476

Q35039549-C1ED8B58-433E-473E-857A-29614FCAEB35

P2093

Q35039549-24171DAA-9588-40BB-A090-EC9CB9A46F5C

Q35039549-735249D5-8CCE-486F-A6AE-1A08F46FD9EF

Q35039549-76860494-D99F-4598-80F8-14CE9856C7C4

Q35039549-BE1E435C-4982-4B23-BDDC-004368C053DC

Q35039549-CF0F4E34-9F77-4E97-82E3-707DE3C378D6

P2860

Q35039549-05DF28D9-457D-48FB-AEBE-FC1F7957E922

Q35039549-153ABDFF-CD71-4CF9-88BF-8DAD3E347CA3

Q35039549-2635A87B-49EC-44D0-8B35-7B1FCFEC626D

Q35039549-3DD85A0F-C28E-4082-8544-72E2C396327E

Q35039549-48F53C84-F29A-41A0-A4A9-22DC5E008347

Q35039549-4A5CC8BB-59D8-4C3E-B09C-8BA0092F2D0D

Q35039549-5327C66A-38F9-4AAB-97E8-E119A0A6BBC9

Q35039549-5FF65D93-F14C-4F2B-8464-EBA366030B97

Q35039549-729F0FFE-6C12-44B3-9E93-17F0E6964BE7

Q35039549-8E02DA5C-6216-47A5-BC56-79FF5072FCA8

P304

Q35039549-9425DAC3-E898-4954-8876-3BDF1D5B93BB

P31

Q35039549-8885286F-50DD-48E9-834E-C1375EF390B7

P433

Q35039549-BA8A8EBA-BDF2-4702-90F5-7EE2E93DE18D

P478

Q35039549-97C6FD5F-ED11-490B-B147-F9A2CA9F35DA

P577

Q35039549-9F6B9580-BF13-4CC2-BC5C-CFC24C48163F

P698

Q35039549-8FD683D8-6A0E-4194-ACBF-4D1250B56E97

P932

Q35039549-46F032DF-7141-4351-8128-6FFA01F50AD9

P1433

Texas Heart Institute Journal

P1476

Cardiac dysfunction after cancer treatment.

@en

P2093

Anecita Fadol

http://www.w3.org/2001/XMLSchema#string

Daniela Cardinale

http://www.w3.org/2001/XMLSchema#string

Michael S Ewer

http://www.w3.org/2001/XMLSchema#string

Sandra M Swain

http://www.w3.org/2001/XMLSchema#string

Thomas M Suter

http://www.w3.org/2001/XMLSchema#string

P2860

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Modulation of anthracycline-induced myofibrillar disarray in rat ventricular myocytes by neuregulin-1beta and anti-erbB2: potential mechanism for trastuzumab-induced cardiotoxicity

Risk factors for doxorubicin-induced congestive heart failure

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy.

Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy.

Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition.

Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy.

Trastuzumab-induced cardiotoxicity: clinical and prognostic implications of troponin I evaluation.

Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial.

P304

248-252

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21720462

http://www.w3.org/2001/XMLSchema#string

P932

3113132

http://www.w3.org/2001/XMLSchema#string